Overview of Clinical Cytogenetics

Area of Science:

• Genetics
• Cytogenetics
• Molecular Diagnostics

Background:

• Chromosome analysis is a foundational genetic testing method for constitutional and somatic disorders.
• Abnormalities in chromosome number or structure can cause congenital anomalies, developmental issues, or pregnancy loss.
• Somatic chromosome changes are relevant in malignancies, while constitutional anomalies inform genetic counseling.

Purpose of the Study:

• To introduce chromosomal microarray analysis (CMA) as a recommended first-tier test for developmental disorders.
• To discuss non-invasive prenatal testing/screening (NIPTS) for aneuploidies using cell-free fetal DNA.
• To cover protocols for clinical chromosome studies in nonmalignant tissues.

Main Methods:

• Chromosomal microarray analysis (CMA) for detecting copy number variations.
• Non-invasive prenatal testing/screening (NIPTS) utilizing maternal plasma cell-free fetal DNA (cfDNA).
• Standard cytogenetic analysis for constitutional and nonmalignant tissues.

Main Results:

• CMA is now the recommended first-tier test for developmental delay, intellectual disability, autism, and multiple congenital anomalies.
• NIPTS offers rapid screening for autosomal and sex-chromosome aneuploidies.
• Cytogenetic analysis aids in diagnosing and monitoring tumors and studying chromosomes in nonmalignant conditions.

Conclusions:

• Advanced cytogenetic techniques like CMA and NIPTS have significantly improved the diagnosis of genetic disorders.
• Chromosome analysis remains vital for both prenatal and postnatal genetic evaluations, as well as in oncology.
• These methods provide critical information for genetic counseling and patient management.